Pharmaceutical Bio Association Holds Forum on 'Strengthening the Production Base of Essential Medicines and Raw Materials'

Pharmaceutical Bio Association and Minseok Kim, Democratic Policy Committee Chair, Co-Host
Event on the 19th of This Month

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association and Kim Min-seok, Policy Committee Chair of the Democratic Party of Korea, announced on the 13th that the 6th K-Life Bio Forum will be held on the 19th at the 8th Meeting Room of the National Assembly Members' Office Building, under the theme "Exploring Measures to Strengthen the Production Base of Essential Medicines and Raw Materials."

The association explained that this forum will serve as an opportunity to explore ways to stably produce and supply essential medicines and raw materials amid growing concerns about pharmaceutical supply instability following COVID-19.

According to the association, Korea's self-sufficiency rate for domestic raw materials for pharmaceuticals is only 24.4%, indicating a high dependence on overseas raw materials. As of last year, 46.1% of all raw materials for pharmaceuticals are imported from China and India. Furthermore, the global supply chain has become increasingly unstable due to the infectious disease pandemic and other factors.

Sponsored by the Ministry of Health and Welfare and the Ministry of Food and Drug Safety, this forum will feature Silvia Park, Research Fellow at the Korea Institute for Health and Social Affairs, presenting on "Overseas Support Policies for Essential Medicines (Raw Materials) and Domestic Implications," and Myung-soo Ahn, Head of the Korea Rare and Essential Drugs Center, presenting on "Management and Supply Status of Domestic Essential Medicines (Raw Materials)." Following the presentations, a panel discussion will be held chaired by Dong-chul Seo, Director of the Pharmaceutical Policy Research Institute, with participants including Chang-hyun Oh, Director of the Health Insurance Drug Policy Division at the Ministry of Health and Welfare; Young-jin Ahn, Director of the Pharmaceutical Policy Division at the Ministry of Food and Drug Safety; Seung-in Eom, Executive Director of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association; and Ki-woong Yoo, Executive Director of Dongkook Pharmaceutical.

Those wishing to attend can apply through the Korea Pharmaceutical and Bio-Pharma Manufacturers Association website.

This content was produced with the assistance of AI translation services.